Teva Pharmaceuticals (France)
- Research works
- 6 ▼ 81% vs 2013–17
- Citations
- 86 13.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 29% world 28%
Not ranked overall: Teva Pharmaceuticals (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.2×. Every wedge is a field page.
Which research topics does Teva Pharmaceuticals (France) publish most on?
By volume in 2022–2025: Immune Cell Function and Interaction, Prostate Cancer Treatment and Research, Advanced Radiotherapy Techniques and Prostate Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune Cell Function and Interaction Immunology 0 works
- 2 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
- 3 Advanced Radiotherapy Techniques Radiation 0 works
- 4 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 5 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
- 6 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 7 RNA and protein synthesis mechanisms Molecular Biology 0 works
- 8 DNA and Nucleic Acid Chemistry Molecular Biology 0 works
- 9 RNA modifications and cancer Molecular Biology 0 works
- 10 Protein Structure and Dynamics Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Teva Pharmaceuticals (France)'s research output changed?
Output in 2018–2022 was 81% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Courbevoie
- Fidal
- Saint-Gobain (France)
- Pôle Léonard de Vinci
- Chiesi (France)
- AstraZeneca (France)
- MSD (France)
- Ecole Supérieure d'Ingénieurs Léonard de Vinci
- Informatique Electromagnetisme Electronique Analyse Numerique (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.